100 YEARS OF FRESENIUS
|
|
- Janice Summers
- 6 years ago
- Views:
Transcription
1 6 100 Years of Fresenius 100 YEARS OF FRESENIUS 100 years ago, Dr. Eduard Fresenius set the cornerstone of our business. In the laboratory of his Frankfurt pharmacy he started a small pharmaceutical company that became the global health care group Fresenius. Entrepreneur ial thinking combined with the courage to seize opportunities and make pioneering strategic decisions this has always been the success formula for our dynamic growth.
2 100 Years of Fresenius 7 The commitment to advancing medical progress and helping seriously ill people with our products and services is still at the heart of every thing we do. Fresenius will continue to pursue this goal in the future, setting milestones in medical care for the benefit of human health. This is what Fresenius has stood for over the last 100 years: Forward-Thinking Healthcare.
3 100 YEARS OF FRESENIUS (1) (2) (3) (4) 1912 FOUNDING In October 1912, Dr. Eduard Fresenius, the pharmacist and owner of the Hirsch Pharmacy, which was known locally by its German name, Hirsch-Apotheke, established the pharmacy business Dr. E. Fresenius chemisch-pharmazeutische Industrie KG. The Hirsch Pharmacy was one of Frankfurt s oldest apothecary shops, with a history that could be traced back to The products that Dr. Fresenius produced and sold with his new company included special compounds for colds, such as the nasal ointment Bormelin. The business was successful and grew out of numerous collaborative relationships entered into by Dr. Fresenius with well-known medical specialists. For example, it produced a solution for Nobel Laureate Paul Ehrlich used in his syphilis treatment, Salvarsan: Injectio Fresenius, ultrapure distilled water RELOCATION TO BAD HOMBURG In 1934, Dr. Fresenius relocated his chemical-pharmaceutical company to Bad Homburg. He intensified his focus on the company, which employed around 400 people in the years to follow BRILLIANT IDEAS Dr. Fresenius had many ideas that made his pharmacy and business well known and were often far ahead of their time. One of these was the Unterhaltungsblatt der Hirsch-Apotheke (Hirsch Pharmacy s popular paper), which he published in the early 1930s, to win his customers loyalty and to promote his company s products. He had a courier service still out of the ordinary at that time which allowed the business to make fast delivery of drugs to its customers. Another example of Dr. Fresenius ingenuity was the diet pavilion that he first opened in Bad Homburg in There, Fresenius employees offered visitors to the famous spa town freshly made fruit and vegetable juices during the summer months, and prepared special drinks for dieting patients according to doctors prescriptions. These latter drinks were prepared for people with stomach and digestive ailments who generally could only consume fruits and vegetables in limited amounts. The precisely dosed, freshly squeezed juices were given to patients upon consultation with their doctors and facilitated their intake of essential vitamins. Milk-Mix drinks, an early form of milkshakes, were particularly popular.
4 (5) (6) (7) (8) 1946 A NEW START AFTER DIFFICULT TIMES The Hirsch Pharmacy in Frankfurt was destroyed in the air raids of March While the business premises in Bad Homburg were not damaged by bombing, shortages of raw materials made the resumption of production difficult. Dr. Fresenius died in February 1946, leaving his property to a community of heirs, among them his faster daughter Else Fernau. The community of heirs decided that Else Fernau should take over the pharmacy and the company. She assumed this responsibility after completing her studies in pharmacy in 1951, at the age of 26. From the 1950s, Else Fernau concentrated on relaunching the production at the company in Bad Homburg, and looked to employ specialist staff and assistants. It was the economist and jurist Hans Kröner who offered particularly helpful expert advice. She first consulted him on legal questions, but soon also enlisted his help in developing business strategies for the company. At first, the Bad Homburg site mainly produced infusion solutions, and later Else Fernau and Hans Kröner expanded the product portfolio to a comprehensive range including high-quality special solutions EXPANSION OF PRODUCTION OF INFUSION SOLUTIONS To create space for the production of infusion solutions, Fresenius erected a new building at Gluckensteinweg 5, in Bad Homburg, in Infusion solutions marked the beginning of the company, and in the 1960s the continuous expansion of this field began. This included the development of new nutrition and volume replacement solutions as well as intravenously administered generic drugs ENTERING THE DIALYSIS MARKET Up until the early 1960s, there was little help for patients suffering from acute renal failure. Many patients died because no dialysis machines were available for their treatment. For this reason, in 1966, Fresenius started distributing and maintaining dialysis machines made by manufacturers in the U.S. Through their contact with the medical staff who used them, Fresenius employees acquired knowledge and were then able to develop their own dialysis machines starting in the early 1970s.
5 (9) (10) (11) (12) 1971 A TIME OF EXPANSION A newly established research department opened up new areas of activity in nutritional medicine for the company in the early 1970s. Fresenius employees, in collaboration with research institutes and clinics, developed an effective composition corresponding to the natural amino acid pattern of the potato and the egg. It set new standards in parenteral nutrition. In 1971, in Switzerland and France, the first foreign subsidiaries were established. Today, Fresenius operates all over the world in about 80 countries. In 1974, the new production plant for infusion solutions was opened in St. Wendel, Germany. Today, this site produces highly innovative Polysulfone dialyzers for Fresenius Medical Care GROUNDBREAKING INNOVATIONS IN DIALYSIS In a newly acquired plant in Schweinfurt, Germany, Fresenius commenced production of its own dialysis machines: with the A 2008, dialysis time is reduced by more than half. It was awarded a gold medal at the Leipzig Trade Fair. In 1982, Fresenius developed the Polysulfone membrane, which is still the standard today in dialyzer technology GOING PUBLIC At the end of 1981, the previous limited partnerships (Kommanditgesellschaften) are transferred to a joint stock company. As the principal shareholder, Else Kröner, née Fernau, assumed 95 percent of the original stock and became Chairman of the Supervisory Board, while her husband Hans Kröner became Chairman of the Management Board. With the introduction of preference shares in 1986, Fresenius was listed on the Frankfurt stock exchange. Ordinary shares were introduced in In 2009, the preference shares of Fresenius SE were integrated into Germany s benchmark stock index, the DAX. From 2007 on, Fresenius has operated as a European company (Societas Europaea or SE) FRESENIUS MEDICAL CARE AND FRESENIUS VAMED In 1996, the new business segment Fresenius Medical Care emerged from the merger of National Medical Care and Fresenius worldwide dialysis business. In the same year, Fresenius was able to purchase the majority interest in VAMED AG. VAMED had been founded for the planning and construction of the Vienna General Hospital in 1982.
6 (13) (14) (15) 1999 FRESENIUS KABI In 1999, the business segment Fresenius Kabi was created through the acquisition of the international infusions business of the American-Swedish company Pharmacia & Upjohn. Numerous additional acquisitions around the world followed, including the U.S. company APP (American Pharmaceutical Partners) in This took Fresenius Kabi into the North American pharmaceuticals market and made it one of the world s leading suppliers of generic IV drugs FRESENIUS HELIOS In 2005, Fresenius acquired the private hospital operator HELIOS Kliniken GmbH and merged it with the Wittgensteiner hospitals, which it had acquired in The result of this was the creation of the new business segment Fresenius Helios, which today is one of the largest private hospital operators in Germany CHANGE IN LEGAL FORM The change of the company s legal form into a partnership limited by shares Kommanditgesellschaft auf Aktien (KGaA) took place in combination with the conversion of all preference shares into ordinary shares YEARS OF FRESENIUS In its centennial year, Fresenius ended the fiscal year with new records for sales and earnings. Approximately 170,000 employees have dedicated themselves at Fresenius to the service of health in about 100 countries worldwide. (1) The Hirsch Pharmacy in Frankfurt at the time of the company s founding. (2) Bormelin ointment for the treatment of swollen mucous membranes in the nose. (3) The employees of Dr. Eduard Fresenius chemisch-pharmazeutische Industrie KG. Front, sitting, with hat: Dr. Fresenius. (4) Brilliant ideas: The diet pavilion on the terrace of the Kurhaus in Bad Homburg. (5) Else Fernau, who worked at the Hirsch Pharmacy during her studies, takes over management of the company in (6) Company signet from the mid-1940s. (7) Else Fernau among her colleagues and construction workers at the toppingout ceremony for the new premises at Gluckensteinweg 5. (8) Machines in the new building from 1955 in Bad Homburg. (9) A bottle washing system in the St. Wendel plant. (10) In the field of dialysis, Fresenius closely collaborated with doctors and clinics from the very start. Pictured here is Else Kröner together with the medical director of the Bad Homburg hospital, in Germany, Dr. Rossenheck, and the district administrator, Dr. Jürgens, in front of the clinic s first A 2008 C. (11) Fresenius makes significant contributions to the development of capillary dialyzers. The capillary dialyzer is now the standard in dialysis. (12) Press conference held upon entry into the stock exchange in Frankfurt in (13) Production of IV drugs at Fresenius Kabi. (14) 2005: New hospital building in Berlin-Buch, the most state-of-the-art hospital building in Europe at the time. (15) Headquarters of Fresenius SE & Co. KGaA.
FORWARD THINKING HEALTHCARE
AT A 2018 GLANCE 02 FORWARD THINKING HEALTHCARE Fresenius is a global healthcare group offering high-quality products and services for dialysis, hospitals, and outpatient treatment. With over 270,000 employees
More informationAnnual General Meeting of Fresenius SE & Co. KGaA on May 13, Speech of Dr. Ulf M. Schneider, Chairman of the Management Board
Annual General Meeting of Fresenius SE & Co. KGaA on May 13, 2016 Speech of Dr. Ulf M. Schneider, Chairman of the Management Board The spoken word has precedence. Good morning, ladies and gentlemen. On
More informationExcellent sales and earnings growth Earnings outlook raised
Press Release August 3, 2010 Matthias Link Corporate Communications Fresenius SE Else-Kröner-Straße 1 61352 Bad Homburg Germany T +49 6172 608-2872 F +49 6172 608-2294 Matthias.Link@fresenius.com www.fresenius.com
More informationExcellent start into 2011 Fresenius raises 2011 sales and earnings outlook
Press Release May 4, 2011 Matthias Link Konzern-Kommunikation Fresenius SE & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg Germany T +49 6172 608-2872 F +49 6172 608-2294 Matthias.Link@fresenius.com
More informationFresenius Investor News
Analysts Meeting and Live video webcast today Fresenius Medical Care at 2.30 p.m. CET / 8.30 a.m. EDT Fresenius AG at 4.30 p.m. CET / 10.30 a.m. EDT health care worldwide May 4, 2005 Contact: Birgit Grund
More informationSales and net income reach all-time highs 6% dividend increase proposed Positive Group outlook for 2015
Investor News February 25, 205 Birgit Grund Senior Vice President Investor Relations Fresenius SE & Co. KGaA Else-Kröner-Straße 6352 Bad Homburg Germany T +49 672 608-2485 F +49 672 608-2488 birgit.grund@fresenius.com
More informationHealth Care Worldwide. Crédit Suisse Global Credit Products Conference October 1, Barcelona
Health Care Worldwide Crédit Suisse Global Credit Products Conference October 1, 2015 - Barcelona Safe Harbor Statement This presentation contains forward-looking statements that are subject to various
More informationFresenius Medical Care and Fresenius Kabi confirm guidance for 2009, Fresenius Helios and Fresenius Vamed raise their outlook
Press Release August 4, 2009 Joachim Weith Senior Vice President Corporate Communications and Public Affairs Fresenius SE Else-Kröner-Straße 1 61352 Bad Homburg Germany T +49 6172 608-2101 F +49 6172 608-2294
More informationQ1 3/2009: Strong organic sales growth achieved Outlook for 2009 fully confirmed
Investor News November 3, Birgit Grund Senior Vice President Investor Relations Fresenius SE Else-Kröner-Straße 1 61352 Bad Homburg Germany T +49 6172 608-2485 F +49 6172 608-2488 ir-fre@fresenius.com
More informationFresenius makes excellent start to 2018, with strong sales and net income growth in constant currency
Investor News Markus Georgi Senior Vice President Investor Relations Fresenius SE & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg Germany T +49 6172 608-2485 F +49 6172 608-2488 markus.georgi@fresenius.com
More informationAnnual General Meeting Fresenius SE Welcome. May 12, 2010
Annual General Meeting Fresenius SE Welcome May 12, 2010 Agenda I. Financial Results 2009 II. Share Price Development III. 1 st Quarter 2010 and Outlook IV. Share Conversion and Change of Legal Form Page
More informationFresenius Investor News
health care worldwide October 31, 2006 Contact: Birgit Grund Fresenius AG Investor Relations Tel. ++49-6172 - 608 2485 Fax ++49-6172 - 608 2488 e-mail: ir-fre@fresenius.de Internet: www.fresenius-ag.com
More informationFresenius reports 15th consecutive record year Significant investments into medium-term growth in FY/18 and FY/19 Healthy medium-term growth targets
Investor News February 20, 209 Markus Georgi Senior Vice President Investor Relations Fresenius SE & Co. KGaA Else-Kröner-Straße 6352 Bad Homburg Germany T +49 672 608-2485 F +49 672 608-2488 markus.georgi@fresenius.com
More informationA Leading Global Health Care Group
A Leading Global Health Care Group Roadshow Benelux June 29/30, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.
More informationFresenius Investor News
health care worldwide February 22, 2007 Contact: Birgit Grund Fresenius AG Investor Relations Tel. ++49-6172 - 608 2485 Fax ++49-6172 - 608 2488 e-mail: ir-fre@fresenius.de Internet: www.fresenius-ag.com
More informationFresenius Investor News
health care worldwide August 3, 2006 Contact: Birgit Grund Fresenius AG Investor Relations Tel. ++49-6172 - 608 2485 Fax ++49-6172 - 608 2488 e-mail: ir-fre@fresenius.de Internet: www.fresenius-ag.com
More informationA Leading Global Health Care Group
A Leading Global Health Care Group Frankfurt stock exchange: FRE US ADR program: FSNUY www.fresenius.com/investors General Presentation, Fresenius SE & Co. KGaA, Investor Relations Copyright, August 2016
More informationA Leading Global Health Care Group
A Leading Global Health Care Group Roadshow Copenhagen October 6, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.
More informationA LEADING GLOBAL HEALTH CARE GROUP. Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY
A LEADING GLOBAL HEALTH CARE GROUP Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY www.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains forward-looking statements
More informationQuarterly Financial Report of Fresenius Group
Quarterly Financial Report of Fresenius Group applying International Financial Reporting Standards (IFRS) 1 st Quarter 2012 2 CONTENT 3 Fresenius Group figures at a glance 5 Fresenius share 6 Management
More informationQuarterly Financial Report of Fresenius Group
Quarterly Financial Report of Fresenius Group applying United States Generally Accepted Accounting Principles (U.S. GAAP) 1 st 3 rd Quarter and 3 rd Quarter 2011 2 CONTENT 3 Fresenius Group figures at
More informationQuarterly Financial Report of Fresenius Group
Quarterly Financial Report of Fresenius Group applying International Financial Reporting Standards (IFRS) 1 st Quarter 2015 2 TABLE OF CONTENTS 3 Fresenius Group figures at a glance 5 Fresenius share 6
More informationAnnual General Meeting of Fresenius SE & Co. KGaA on May 12, Speech of Stephan Sturm, Chairman of the Management Board
Annual General Meeting of Fresenius SE & Co. KGaA on May 12, 2017 Speech of Stephan Sturm, Chairman of the Management Board The spoken word has precedence. Dear Shareholders, Welcome to the Annual General
More informationQuarterly Financial Report of Fresenius Group
Quarterly Financial Report of Fresenius Group applying International Financial Reporting Standards (IFRS) 1 st Half and 2 nd Quarter 2018 2 TABLE OF CONTENTS 3 Fresenius Group figures at a glance 5 Fresenius
More informationQuarterly Financial Report of Fresenius Group
Quarterly Financial Report of Fresenius Group applying International Financial Reporting Standards (IFRS) 1 st 3 rd Quarter and 3 rd Quarter 2010 2 CONTENT 3 Fresenius Group figures at a glance 5 Fresenius
More informationQuarterly Financial Report of Fresenius Group
Quarterly Financial Report of Fresenius Group applying International Financial Reporting Standards (IFRS) 1 st 3 rd Quarter and 3 rd Quarter 2017 2 TABLE OF CONTENTS 3 Fresenius Group figures at a glance
More informationCompany Presentation. September Frankfurt stock exchange: FRE US ADR program: FSNUY
Company Presentation September 2018 Frankfurt stock exchange: FRE US ADR program: FSNUY www.fresenius.com/investors Safe Harbor Statement This presentation contains forward-looking statements that are
More informationAnnual General Meeting. Fresenius Medical Care AG & Co. KGaA
Annual General Meeting Fresenius Medical Care AG & Co. KGaA Speech to the Shareholders by Dr. Ben J. Lipps May 10, 2012 Spoken word takes precedence 1 Slide 1: Welcome Welcome to our Annual General Meeting
More informationQuarterly Financial Report of Fresenius Group
Quarterly Financial Report of Fresenius Group applying International Financial Reporting Standards (IFRS) 1 st Half and 2 nd Quarter 2010 2 CONTENT 3 Fresenius Group figures at a glance 5 Fresenius shares
More informationConference Call Q3/2016 Results
Conference Call Q3/206 Results Bad Homburg, 27 October 206 Frankfurt stock exchange: FRE US ADR program: FSNUY www.fresenius.com/investors Safe Harbor Statement This presentation contains forward-looking
More informationQuarterly Financial Report of Fresenius Group
Quarterly Financial Report of Fresenius Group applying International Financial Reporting Standards (IFRS) 1 st Quarter 2013 2 TABLE OF CONTENTS 3 Fresenius Group figures at a glance 5 Fresenius share 6
More informationCompany Fresenius Medical Care. Issue 2009 Language english. at a glance 2009
Company Fresenius Medical Care Content At a glance Issue 2009 Language english at a glance 2009 FrEsEnius MEDiCal CarE Fresenius Medical Care is the world s largest integrated provider of products and
More informationFresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile
Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business
More informationConsolidated Financial Statements and Management Report of Fresenius SE, Bad Homburg v.d.h. at December 31, 2009
2009 Consolidated Financial Statements and Management Report of Fresenius SE, Bad Homburg v.d.h. at December 31, 2009 applying Section 315a HGB in accordance with International Financial Reporting Standards
More informationFresenius Kabi Compounding Canton, MA
Fresenius Kabi Compounding Canton, MA Fresenius Kabi - Boston Compounding Andy Basso Operations Director Agenda Existential question: Why am I here? Who is Fresenius-Kabi? What does our Canton Facility
More informationConference Call FY/17 Results
Conference Call FY/17 Results Bad Homburg, 27 February 2018 Frankfurt stock exchange: FRE US ADR program: FSNUY www.fresenius.com/investors Safe Harbor Statement This presentation contains forward-looking
More informationapplying 315a HGB in accordance with International Financial Reporting Standards
CONSOLIDATED FINANCIAL STATEMENTS AND MANAGEMENT REPORT OF FRESENIUS AG, BAD HOMBURG V.D.H. at December 31, 2006 applying 315a HGB in accordance with International Financial Reporting Standards CONTENTS
More informationCONFERENCE CALL 2015 RESULTS. Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY
CONFERENCE CALL 205 RESULTS Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY www.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains forward-looking statements that
More informationHealth Care Worldwide. Bank of America, 2007 Health Care Conference, May 30, 2007
Health Care Worldwide Bank of America, 2007 Health Care Conference, May 30, 2007 1 Fresenius This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future
More informationQuarterly Financial Report of Fresenius Group
Quarterly Financial Report of Fresenius Group applying International Financial Reporting Standards (IFRS) 1 st 3 rd Quarter and 3 rd Quarter 2018 2 TABLE OF CONTENTS 3 Fresenius Group figures at a glance
More informationAdvances in Stem Cell Aging
Advances in Stem Cell Aging Else Kröner-Fresenius Symposia Vol. 3 Series Editor S. Pahernik Heidelberg Advances in Stem Cell Aging Volume Editor Karl Lenhard Rudolph Ulm 20 figures in color, 2012 Basel
More informationMerger Documentation
This document is an English translation of the original German language document. The translation is exclusively for convenience purposes. Only the original German language document is authoritative and
More informationAnnual General Meeting. Fresenius Medical Care AG & Co. KGaA
Annual General Meeting Fresenius Medical Care AG & Co. KGaA Speech to the Shareholders by Dr. Ben J. Lipps May 11, 2010 Spoken word takes precedence Fresenius Medical Care AG & Co. KGaA - 1 - Chart 1:
More informationAnalyst Conference Call Q1/13 Results. April 30, 2013
Analyst Conference Call Q1/13 Results April 30, 2013 Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could
More informationConference Call Q1/14 Results. May 6, 2014
Conference Call Q1/14 Results May 6, 2014 Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially
More informationFresenius Medical Care
2012 P r o f i l e Fresenius Medical Care Vision Creating a future worth living. For dialysis patients. Worldwide. Every day. More than three decades of experience in dialysis, innovative research, the
More informationCity of Industry Innovative Efficient Sustainable
City of Industry Innovative Efficient Sustainable Ensemble Melsungen is the home of B. Braun, one of the leading manufacturers of medical technology. The company headquarters reflects the almost 180 year
More informationAlliance Healthcare Deutschland a plus of services
Backgrounder Alliance Healthcare Deutschland Corporate Profile Alliance Healthcare Deutschland a plus of services The business model of Alliance Healthcare Deutschland focuses on support for the independent
More informationJoint Report. of the Management Board of the General Partner of. Fresenius Medical Care AG & Co. KGaA, Fresenius Medical Care Management AG, and
- convenience translation - Joint Report of the Management Board of the General Partner of Fresenius Medical Care AG & Co. KGaA, Fresenius Medical Care Management AG, and the Management Board of Fresenius
More informationConsolidated Financial Statements and Management Report of Fresenius SE & Co. KGaA, Bad Homburg v. d. H. at December 31, 2014
2014 Consolidated Financial Statements and Management Report of Fresenius SE & Co. KGaA, Bad Homburg v. d. H. at December 31, 2014 applying Section 315a HGB in accordance with International Financial Reporting
More informationJ.P. Morgan 37 th Annual Healthcare Conference
J.P. Morgan 37 th Annual Healthcare Conference San Francisco, 7-8 January 2019 Frankfurt stock exchange: FRE US ADR program: FSNUY www.fresenius.com/investors Safe Harbor Statement This presentation contains
More informationFresenius Kabi at a glance
Fresenius Kabi at a glance in million W 1998 1) 1999 Segment Segment Total Products 2) Services Sales 711 964 870 94 EBIT (operating profit) 73 79 70 9 Net income 3) 37 Investments 30 80 Operating cash
More informationRating Methodology by Sector. Pharmaceuticals
Last Updated: December 7, 2011 Rating Methodology by Sector Pharmaceuticals Pharmaceuticals are mainly categorized into ethical drugs, which are provided to patients by hospital pharmacies or by dispensing
More informationAnnual General Meeting May 28, Address to the shareholders of Fresenius AG. Dr. Gerd Krick. Chairman of the Managing Board
Address to the shareholders of Fresenius AG Page 1 of 31 Annual General Meeting May 28, 2003 Address to the shareholders of Fresenius AG Dr. Gerd Krick Chairman of the Managing Board The spoken word is
More informationHSBC Healthcare Day. Frankfurt, 23 November Frankfurt stock exchange: FRE US ADR program: FSNUY
HSBC Healthcare Day Frankfurt, 23 November 2017 Frankfurt stock exchange: FRE US ADR program: FSNUY www.fresenius.com/investors Safe Harbor Statement This presentation contains forward-looking statements
More informationFresenius SE & Co. KGaA
ANNUAL REPORT 2017 Table of contents 2 To our shareholders 6 Summary of the fiscal year 8 Fresenius share 12 Business segments 12 Fresenius Medical Care 14 Fresenius Kabi 16 Fresenius Helios 18 Fresenius
More informationFresenius SE & Co. KGaA. Bad Homburg v.d.h.
Fresenius SE & Co. KGaA Bad Homburg v.d.h. 2010 = b Financial Statements = b Management Report = b Report of the Supervisory Board - Convenience Translation - The German version of these Financial Statements
More informationUNDERSTAND WHAT COUNTS. How we further strengthen our market position and generate profitable growth A SUCCESSFUL COURSE FOR THAT WE FUTURE
UNDERSTAND 2015 WHICH INNOVATIVE SOLUTIONS ARE IMPOR TANT TO OUR PATIENTS THAT WE HAVE SET THE COURSE FOR A SUCCESSFUL FUTURE How we further strengthen our market position and generate profitable growth
More informationActavis Italy. Nerviano Plant
Actavis Italy Nerviano Plant Starting out in 1901 in Jerusalem The company known today as Teva was established as a small wholesale drug business by Chaim Salomon, Moshe Levin and Yitschak Elstein. (They
More informationRIGHT DELIVERED ON TARGET. Spotlight 1 / 2
48 Spotlight 1 DELIVERED 1 / 2 Even when the rest of the world is sleeping, Biebesheim Logistics Center is up and running. 24 hours a day, six days a week, life-saving goods for dialysis patients arrive
More informationFacts and Figures eople
Facts and Figures 2012 eople The company The company Content 2 Sales in million The is an independent, owner-operated The company The at a glance 2 3 2012 highlights hameln rds 4 hameln pharma 5 hameln
More informationFacts about Tönnies. Sales (worldwide) 2015: 6.30 billion EUR
Facts about Tönnies Tönnies is a multi-level company with business activities in the food industry around the world. The six business sectors are Meat, Convenience, Sausages, Ingredients, Logistics and
More informationKSP ID. Chairman. Dr. Abdul Rahman Abdullah Al-Awadi. Date of Establishment. 15 th May Ownership
KSP ID Chairman Dr. Abdul Rahman Abdullah Al-Awadi Date of Establishment 15 th May 1994 Ownership A joint venture between National Pharmaceutical Industries Co. & Securities Group Co. Products Manufacturing,
More informationWalgreens Rx Supply Chain Transforming to an Outsource Model
Walgreens Rx Supply Chain Transforming to an Outsource Model Michael Bleser Divisional Vice President, Rx Supply Chain & Analytics April 2, 2014 2013 Walgreen Co. All rights reserved. Background BS-Finance
More informationBUSINESS OBJECTIVES AND FUTURE PLANS
BUSINESS OBJECTIVES AND STRATEGIES Our objectives are to consolidate and strengthen our position to become one of the leading distributors of pharmaceutical products in Zhejiang province. To further develop
More informationMay 3, 2016 INVESTOR NEWS. First quarter 2016
May 3, 2016 INVESTOR NEWS First quarter 2016 Fresenius Medical Care reports strong start to the year 2016 - Group revenue increased +6%, strong net income growth of +9% - North America: revenue +10%, significant
More informationFRESENIUS GROUP Earnings Balance sheet Profitability Dividend per ordinary share in Dividend per preference share in Employees (December 31)
COMPETENCE Annual Report 2006 FRESENIUS GROUP IN FIGURES in million 2006 US GAAP 2005 US GAAP 2004 US GAAP 2003 US GAAP 2002 US GAAP Earnings Sales 10,777 7,889 7,271 7,064 7,507 EBIT 1,444 969 845 781
More informationTestimony of Molly Ventrelli Vice President, Regulatory Affairs Fresenius Kabi USA, LLC
Testimony of Molly Ventrelli Vice President, Regulatory Affairs Fresenius Kabi USA, LLC U.S. House of Representatives Energy and Commerce Committee Subcommittee on Health Subcommittee January 30, 2018
More informationBayer CEO Wenning at the inauguration of new production facilities in Shanghai
Investor News Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer CEO Wenning at the inauguration of new production facilities in Shanghai China is of central importance to
More informationRENAL DIALYSIS EQUIPMENT: TECHNOLOGIES AND GLOBAL MARKETS
RENAL DIALYSIS EQUIPMENT: TECHNOLOGIES AND GLOBAL MARKETS HLC164A March 2014 Krishanu Bhattacharjee Project Analyst ISBN: 1-56965-744-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationAudited financial statements of Fresenius ProServe GmbH as at and for the year ending December 31, (German GAAP)
Audited financial statements of Fresenius ProServe GmbH as at and for the year ending December 31, 2016 (German GAAP) Fresenius ProServe GmbH, Bad Homburg v. d. Höhe Balance sheet as of December 31, 2016
More informationFresenius SE & Co. KGaA. Bad Homburg v.d.h. Financial Statements. Management Report. Report of the Supervisory Board
Fresenius SE & Co. KGaA Bad Homburg v.d.h. 2013 Financial Statements Management Report Report of the Supervisory Board - Convenience Translation - The German version of these Financial Statements is legally
More informationCorporate Philosophy and Vision, Brand Mark, Business Management Goals and Other Policies of Mitsubishi Tanabe Pharma Corporation
May 16, 2007 Press Release Tanabe Seiyaku Co., Ltd. Mitsubishi Pharma Corporation Corporate Philosophy and Vision, Brand Mark, Business Management Goals and Other Policies of Mitsubishi Tanabe Pharma Corporation
More informationWhat is a reliable source of practical oncology stability data?
What is a reliable source of practical oncology stability data? Pilar Blasco Chief Pharmacist, Valencia General Hospital, Spain Maria Cammarota Director of Pharmacy, Cardarelli Hospital, Naples, Italy
More informationAn ExampleOf Visual SixSigma, with JMP Scripting at Fresenius Kabi plant Cavezzo - Italy
An ExampleOf Visual SixSigma, with JMP Scripting at Fresenius Kabi plant Cavezzo - Italy JMP DiscoverySummit 2015, Brussels, 25 March 2015 Copyright Fresenius Kabi AG 1 The Fresenius Group Fresenius Medical
More informationSUCCESSFUL BRANDS: LATVIA ESTONIA CROATIA GERMANY UNITED KINGDOM BOSNIA-HERZEGOVINA BULGARIA MACEDONIA SERBIA CZECH REPUBLIC SLOVAKIA FRANCE AUSTRIA
ACCESS TO SUCCESS SUCCESSFUL BRANDS: CROATIA ESTONIA LATVIA BOSNIA-HERZEGOVINA BULGARIA MACEDONIA SERBIA GERMANY UNITED KINGDOM SLOVAKIA CZECH REPUBLIC FRANCE HUNGARY AUSTRIA ITALY ACCESS TO OUR MARKETS
More informationFRESENIUS GROUP IN FIGURES FINANCIAL CALENDAR
FINANCIAL CALENDAR FRESENIUS GROUP IN FIGURES Report on 1 st quarter 2007 Conference call May 2, 2007 in million 2006 US GAAP 2005 US GAAP 2004 US GAAP 2003 US GAAP 2002 US GAAP Annual General Meeting,
More informationLetter to our shareholders
Letter to our shareholders Dear fellow shareholder, 2016 was an exceptional year in exceptional times. We reached a milestone, our 150th anniversary, a celebration of a century and a half of passion for
More informationNews Release. Official Ceremony: Merck KGaA, Darmstadt, Germany, Celebrates 350-Year Company History in Darmstadt. May 3, 2018
News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 May 3, 2018 Official Ceremony: Merck KGaA, Darmstadt, Germany, Celebrates 350-Year Company History in Darmstadt Merck family representative Frank
More informationContinuing Dynamic Efforts to Take On New Challenges in Order to Realize Sustained Growth
Message from the President Continuing Dynamic Efforts to Take On New Challenges in Order to Realize Sustained Growth Tomiya Takamatsu President 19 DyDo Group Holdings Integrated Report 2017 Promoting Our
More informationHealthcare Disrupted From Selling Pills to sell Value The changing Paradigm
Healthcare Disrupted From Selling Pills to sell Value The changing Paradigm Hans-Peter Frank PhD, MBA; Global Head Integrated Solution Vifor Fresenius Medical Care Renal Pharma, a partnership of Vifor
More informationProf. Dr. med. D. Michael Albrecht
Prof. Dr. med. D. Michael Albrecht Medical Director and Spokesman of the Management Board University Hospital Carl Gustav Carus Dresden Member of the Supervisory Board of Fresenius SE & Co. KGaA since
More informationIndustrial On & Off Shore. Top catering and hospitality for workers in extreme conditions
Industrial On & Off Shore Top catering and hospitality for workers in extreme conditions Ligabue is always at your side, effectively supplying quality services Management of catering and hospitality services
More informationAnnual General Meeting Roche Holding Ltd 4 March 2014
r Annual General Meeting Roche Holding Ltd 4 March 2014 Address by Severin Schwan Chief Executive Officer (Check against delivery.) Address by Severin Schwan page 2/11 Shareholders, Ladies and Gentlemen,
More informationFresenius SE & Co. KGaA. Bad Homburg v.d.h.
Fresenius SE & Co. KGaA Bad Homburg v.d.h. 2014 = Financial Statements = Management Report = Report of the Supervisory Board - Convenience Translation - The German version of these Financial Statements
More informationSUPPLY CHAIN CENTER ACUTE CARE PHARMACY
SUPPLY CHAIN CENTER ACUTE CARE PHARMACY FIVE YEARS EXPERIENCE IN A CENTRALIZED STERILE COMPOUNDING SERVICE WITH THE RIVA IV AUTOMATION SYSTEM INTERMOUNTAIN HEALTHCARE THE VISION FOR STERILE COMPOUNDING
More informationSPECTRA LABORATORIES. Laboratory and diagnostic. software for nutrition therapy Hemodiafilters. dialysis-related services
> FRESENIUS MEDICAL CARE FRESENIUS KABI Products and services of our business segments HEMODIALYSIS Machines for Hemodialysis ONLINE Hemodiafiltration Hemofiltration High- and Low-Flux dialyzers (Fresenius
More informationJefferies 2015 Global Healthcare Conference June 3, 2015
Jefferies 2015 Global Healthcare Conference June 3, 2015 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act
More informationCapital Market Day June 12, 2012
Capital Market Day 2012 June 12, 2012 Product Segments IV Drugs John Ducker Member of the Management Board President Region North America Capital Market Day Fresenius Kabi, June 12, 2012 Agenda 1 2 3 4
More informationProduction-based pharmacist a fascinating job.
www.mybayerjob.com Production-based pharmacist a fascinating job These are the interesting tasks that our pharmacists typically undertake in entry-level positions in Production at Bayer HealthCare Pharmaceuticals
More informationA SPMSD Lean Six Sigma Project on how to improve distribution models at customer level. Maurizio Caschera Quality Assurance Manager
A SPMSD Lean Six Sigma Project on how to improve distribution models at customer level Maurizio Caschera Quality Assurance Manager Cold Suplly System & Solutions 2015 Bruxelles 19-20 /03/2015 1 CO00993(1)
More informationData protection notice pursuant to the General Data Protection Regulation (GDPR)
Data protection notice pursuant to the General Data Protection Regulation (GDPR) This data protection notice is designed to inform you of what purposes STADA Arzneimittel AG Stadastraße 2-18. 61118 Bad
More information2017 Arvato At a Glance
Arvato At a Glance 2017 Dear readers, dear friends of Arvato, Arvato is an international service provider. About 70,000 employees in more than 40 countries design and implement innovative solutions for
More informationNovartis Canada. Getting a Global Perspective
Getting a Global Perspective Talking with Jacques Dessureault, Vice-President, Cardiovascular and Metabolism Business Franchise, Novartis Pharmaceuticals Canada You recently spent close to two years in
More informationOutline of the Business Alliance
Notification with Respect to the Basic Agreement Between FUJIFILM Holdings Corporation, Taisho Pharmaceutical Co., Ltd. and Toyama Chemical Co., Ltd. Regarding a Strategic Capital and Business Alliance
More informationConvenience Translation
Convenience Translation Ordinary General Meeting 2010 Explanations on the Rights of Shareholders according to Section 278 (3) in connection with Section 122 (2), Section 126 (1), Sections 127, 131 (1)
More informationR&D and Intellectual Property
R&D and Intellectual Property R&D and Intellectual Toray is built on research and development, and as a manufacturer of basic materials, will continue to pursue highly original advances and technologies.
More information